Related Experiment Video
Updated: Sep 10, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Conditional Survival in Patients with Locally Advanced Rectal Cancer and Pathologic Complete Response: Results from
Carlos Cerdán Santacruz1, Oscar Cano-Valderrama2, Laura Melina Fernández3
1Hospital Universitario de la Princesa, 28006 Madrid, Spain.
Patients with locally advanced rectal cancer achieving pathological complete response after neoadjuvant therapy can have adapted follow-up. Recurrence-free survival improves over time, with late recurrences being rare, reducing patient burden.
Area of Science:
- Oncology
- Clinical Medicine
- Surgical Oncology
Background:
- Locally advanced rectal cancer (LARC) patients achieving pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) have a favorable prognosis.
- Current follow-up protocols for these patients are often similar to those with worse prognoses, leading to unnecessary psychological and economic burdens.
Purpose of the Study:
- To analyze oncological outcomes and recurrence-free survival (RFS) in LARC patients who achieved pCR after NCRT and surgery.
- To evaluate the potential for adapting follow-up strategies based on conditional survival analysis.
Main Methods:
- Retrospective, observational, multicenter study using data from the Spanish Rectal Cancer Project.
- Included 815 LARC patients who underwent curative surgery post-NCRT and achieved pCR.
- Conditional survival models were used to analyze RFS at 1, 2, and 3 years post-surgery.
Main Results:
- The overall 5-year RFS was 86.5%.
- For patients surviving 1, 2, and 3 years post-surgery, RFS probabilities were 89.4%, 92.9%, and 95.2%, respectively.
- The probability of recurrence significantly decreased over time, with only 0.6% recurrence risk after 3 years.
Conclusions:
- Follow-up intensity for LARC patients with pCR post-NCRT and surgery can be adapted.
- Conditional survival data demonstrate that RFS probability increases with time, supporting less intensive monitoring for long-term survivors.
- Late recurrences (>3 years) are exceptional, suggesting a potential for de-escalation of surveillance.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022